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Supplementary figure 1. COVID-19 government index response index classification. 
 
 
The median Oxford COVID-19 government response index score was calculated for each patient as a median average between local emergence of COVID-19 or data 
of diagnosis (whichever was latest) to the date of operation or cessation of follow-up if the patient remained non-operated. A representative example country is shown. 
The final classification is shown beneath each patient example.  
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A median average COVID-19 stringency index score was calculated for each patient based on the date of first local COVID-19 cases up to the date of operation 
(operated patients) or cessation of follow-up (non-operated patients) in each included country (Supplementary figure 1). Patients were grouped based on their 
corresponding COVID-19 stringency index light restrictions (median index score <20 (orange)), moderate lockdown (median index score 20-60) and full lockdown 








Percentages displayed represent proportion operated by group  
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Surgical capacity defined as patients booked for surgery undergoing an operation during the follow-up window. Full lockdown defined as full weeks with COVID-19 
stringency index score >60. Upon testing for a non-linear relationship between weeks in full lockdown and the outcome variable using a penalised spline on the 
exposure, a significant non-linear relationship was demonstrated (p<0.001). This was confirmed graphically using a spline plot. Therefore, weeks in lockdown were 










Plot displays patients that went straight to surgery (no neoadjuvant therapy only). Mean interval by group displayed. The point of system 'friction' was different across income 
and lockdown groups. Lockdown typically increased the interval from decision to operation across all settings. The interval from diagnosis to decision was a higher contributor 
to overall delay in UMICs and LMICs than in HICs.  
 
 8 
Supplementary table 1a. Cancer types across World Bank income groups 
 
Cancer location High income 
Upper middle  
income 
Lower middle  
income 
Total 
Head and neck 2480 (15.6) 448 (23.7) 589 (26.2) 3517 (17.6) 
Colon 2955 (18.6) 287 (15.2) 186 (8.3) 3428 (17.1) 
Rectal 1235 (7.8) 138 (7.3) 139 (6.2) 1512 (7.6) 
Gastric 515 (3.2) 119 (6.3) 89 (4.0) 723 (3.6) 
Oesophageal 391 (2.5) 23 (1.2) 37 (1.6) 451 (2.3) 
Thoracic 1172 (7.4) 10 (0.5) 10 (0.4) 1192 (6.0) 
Liver 649 (4.1) 38 (2.0) 88 (3.9) 775 (3.9) 
Pancreatic 571 (3.6) 77 (4.1) 128 (5.7) 776 (3.9) 
Sarcoma 353 (2.2) 17 (0.9) 68 (3.0) 438 (2.2) 
Prostate 511 (3.2) 13 (0.7) 13 (0.6) 537 (2.7) 
Kidney or upper tract urothelial 389 (2.5) 22 (1.2) 31 (1.4) 442 (2.2) 
Bladder 108 (0.7) 5 (0.3) 34 (1.5) 147 (0.7) 
Gynaecological 1776 (11.2) 236 (12.5) 157 (7.0) 2169 (10.8) 
Breast 2758 (17.4) 458 (24.2) 680 (30.2) 3896 (19.5) 
Intracranial* 653 (2.9) 110 (3.7) 120 (4.7) 883 (3.2) 
 
Percentages expressed of column total. Country income defined in accordance with World Bank income (2019/20) classifications. Lower 
middle income included patients from both lower-middle income and low-income countries. *Surgical intent data was unavailable for 
intracranial tumours. Treatment pathways and outcomes related to delay were considered too disparate from other tumour types for combined 






Supplementary table 1b. Patients included by country and income group 
 
High income Upper middle income Lower middle income 
Country Patients Centres Country Patients Centres Country Patients Centres 
Australia 716 (4.5) 18 Argentina 71 (3.8) 2 Egypt 287 (12.8) 12 
Austria 163 (1.0) 2 Azerbaijan 3 (0.2) 1 Ghana 14 (0.6) 1 
Barbados 19 (0.1) 1 Botswana 9 (0.5) 1 India 1566 (69.6) 15 
Belgium 25 (0.2) 3 Brazil 430 (22.7) 8 Indonesia 90 (4.0) 1 
Canada 373 (2.4) 10 Colombia 138 (7.3) 5 Morocco 140 (6.2) 1 
Chile 50 (0.3) 2 Guatemala 1 (0.1) 1 Nigeria 50 (2.2) 6 
Croatia 19 (0.1) 1 Jordan 31 (1.6) 2 Pakistan 81 (3.6) 8 
Czech Republic 3 (0.0) 1 Libya 66 (3.5) 3 Philippines 5 (0.2) 1 
Denmark 174 (1.1) 2 Malaysia 194 (10.3) 7 Reunion 3 (0.1) 1 
Finland 103 (0.6) 2 Mexico 128 (6.8) 1 Sudan 11 (0.5) 3 
France 508 (3.2) 14 Peru 34 (1.8) 1 Syria 2 (0.1) 1 
Germany 399 (2.5) 9 Romania 17 (0.9) 2 Uganda 1 (0.0) 1 
Greece 266 (1.7) 11 Russia 4 (0.2) 1 Yemen 2 (0.1) 1 
Hong Kong  62 (0.4) 3 Serbia 179 (9.5) 4 
  
Hungary 45 (0.3) 1 South Africa 92 (4.9) 1 
Ireland 177 (1.1) 8 Sri Lanka 19 (1.0) 1 
Italy 2291 (14.4) 47 Turkey 475 (25.1) 15 
Japan 19 (0.1) 1 
  
  
Kuwait 7 (0.0) 1 
Netherlands 234 (1.5) 7 
Oman 2 (0.0) 1 
Portugal 435 (2.7) 15 
Saudi Arabia 373 (2.4) 11 
Singapore 191 (1.2) 2 
Slovak Republic 3 (0.0) 1 
Slovenia 51 (0.3) 1 
Spain 1478 (9.3) 38 
Sweden 171 (1.1) 5 
Switzerland 127 (0.8) 5 
United Kingdom 6160 (38.8) 113 
United States 1219 (7.7) 21 
 
Percentages expressed of column total.   
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Supplementary table 2. Characteristics for patients awaiting surgery during light restrictions, moderate and 
full lockdowns 
 









Health system factors 
Weeks in full lockdown Mean (SD) 2.4 (1.7) 5.5 (2.9) 12.7 (5.4) <0.001 
World Bank Income Classification 
High income 4089 (90.4) 3130 (85.8) 8644 (73.1) 
<0.001 Upper middle income 228 (5.0) 325 (8.9) 1329 (11.2) 
Lower middle income 204 (4.5) 191 (5.2) 1854 (15.7) 
Community SARS-CoV-2 case 
notification rate* 
High income, low COVID 2952 (65.3) 1144 (31.4) 367 (3.1) 
<0.001 
High income, high COVID 1137 (25.1) 1986 (54.5) 8277 (70.0) 
Upper middle income, low COVID 228 (5.0) 248 (6.8) 262 (2.2) 
Upper middle income, high COVID 0 (0.0) 77 (2.1) 1067 (9.0) 
Lower middle income, low COVID 204 (4.5) 181 (5.0) 1205 (10.2) 
Lower middle income, high COVID 0 (0.0) 10 (0.3) 649 (5.5) 
Patient factors 
Age 
<50 years 775 (17.1) 562 (15.4) 2355 (19.9) 
<0.001 
50-59 years 962 (21.3) 764 (21.0) 2409 (20.4) 
60-69 years 1222 (27.0) 1048 (28.7) 3144 (26.6) 
70-79 years 1176 (26.0) 927 (25.4) 2740 (23.2) 
>80 years 386 (8.5) 345 (9.5) 1179 (10.0) 
Sex 
Female 2711 (60.0) 2100 (57.6) 6666 (56.4) 
<0.001 
Male 1810 (40.0) 1546 (42.4) 5161 (43.6) 
ASA grade 
Grade 1-2 3274 (72.7) 2493 (68.6) 8381 (71.2) 
<0.001 Grade 3-5 1230 (27.3) 1143 (31.4) 3382 (28.8) 
Missing 17 10 64 
ECOG performance score 
0 2785 (63.0) 2157 (60.3) 6595 (56.7) 
<0.001 
1 1186 (26.8) 1005 (28.1) 3645 (31.3) 
>2 448 (10.1) 417 (11.7) 1397 (12.0) 
Missing 102 67 190 
Current smoker 
No 4026 (89.1) 3202 (87.8) 10437 (88.2) 
0.195 
Yes 495 (10.9) 444 (12.2) 1390 (11.8) 
Pre-existing respiratory condition 
No 3950 (87.4) 3219 (88.3) 10571 (89.4) 
0.001 
Yes 571 (12.6) 427 (11.7) 1256 (10.6) 
Revised Cardiac Risk Index 
0 1355 (30.0) 1121 (30.7) 3603 (30.5) 
0.032 
1 2331 (51.6) 1820 (49.9) 6092 (51.5) 
2 691 (15.3) 541 (14.8) 1684 (14.2) 
>3 144 (3.2) 164 (4.5) 448 (3.8) 
Disease factors 
Disease stage 
Early disease 2582 (57.4) 1960 (54.4) 6226 (54.2) 
<0.001 Advanced/nodal disease 1919 (42.6) 1641 (45.6) 5258 (45.8) 
Missing 20 45 343 
Site specific cancer 
Head and neck 672 (14.9) 649 (17.8) 2193 (18.5) 
<0.001 
Colon 902 (20.0) 609 (16.7) 1913 (16.2) 
Rectal 313 (6.9) 272 (7.5) 926 (7.8) 
Gastric 83 (1.8) 148 (4.1) 492 (4.2) 
Oesophageal 62 (1.4) 59 (1.6) 329 (2.8) 
Thoracic 350 (7.7) 197 (5.4) 645 (5.5) 
Liver 139 (3.1) 165 (4.5) 471 (4.0) 
Pancreatic 138 (3.1) 145 (4.0) 493 (4.2) 
Sarcoma 76 (1.7) 89 (2.4) 273 (2.3) 
Prostate 123 (2.7) 61 (1.7) 353 (3.0) 
Kidney or upper tract urothelial 119 (2.6) 66 (1.8) 257 (2.2) 
Bladder 35 (0.8) 24 (0.7) 88 (0.7) 
Gynaecological 547 (12.1) 439 (12.0) 1183 (10.0) 
Breast 962 (21.3) 723 (19.8) 2211 (18.7) 
Treatment factors 
Neoadjuvant therapy 
No neoadjuvant 4177 (92.4) 3187 (87.4) 9600 (81.2) 
<0.001 Neoadjuvant therapy, standard care 272 (6.0) 340 (9.3) 1287 (10.9) 
Neoadjuvant therapy, COVID decision 72 (1.6) 119 (3.3) 940 (7.9) 
Percentages expressed of column total. SD=Standard deviation. ASA=American Society of Anaesthesiologists classification. ECOG=Eastern Cooperative Oncology Group. 
COVID=Coronavirus disease 2019. SARS-CoV-2=severe acute respiratory syndrome coronavirus 2. *Community SARS-CoV-2 rates were defined as the median 14-day cumulative 
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case notification rate per 100,000 population between the date of local emergence of the pandemic up to the date of surgery for operated patients or cessation of follow-up (31st August 
2020) for non-operated patients, and were stratified by World Bank income group to account for differences in access to SARS-CoV-2 testing and reporting across settings. 
Supplementary table 3. Characteristics of operated and non-operated patients during COVID-19 
 
  
Status at cessation of 
follow-up 
 
Factor Levels Non-operated Operated P-value 
Health system factors 
COVID-19 Stringency Index group 
Light restrictions 26 (1.3) 4495 (25.0) 
<0.001 Moderate lockdown 201 (10.0) 3445 (19.1) 
Full lockdown 1775 (88.7) 10052 (55.9) 
Weeks in lockdown (COVID-19 stringency index) Mean (SD) 20.3 (5.7) 7.8 (5.0) <0.001 
World Bank Income Classification 
High income 1342 (67.0) 14521 (80.7) 
<0.001 Upper middle income 187 (9.3) 1704 (9.5) 
Lower middle income 473 (23.6) 1776 (9.9) 
Community SARS-CoV-2 case notification rate* 
High income, low COVID 1297 (64.8) 10103 (56.1) 
<0.001 
High income, high COVID 58 (2.9) 680 (3.8) 
Upper middle income, low COVID 129 (6.4) 1024 (5.7) 
Upper middle income, high COVID 82 (4.1) 1508 (8.4) 
Lower middle income, low COVID 391 (19.5) 268 (1.5) 
Lower middle income, high COVID 45 (2.2) 4418 (24.5) 
Patient factors 
Age 
<50 years 405 (20.2) 3287 (18.3) 
0.001 
50-59 years 399 (19.9) 3739 (20.8) 
60-69 years 555 (27.7) 4865 (27.0) 
70-79 years 424 (21.2) 4422 (24.6) 
>80 years 220 (11.0) 1690 (9.4) 
Sex 
Female 1008 (50.3) 10472 (58.2) 
<0.001 
Male 995 (49.7) 7531 (41.8) 
ASA Grade 
Grade 1-2 1380 (70.8) 12777 (71.1) 
0.822 Grade 3-5 568 (29.2) 5190 (28.9) 
Missing 55 36 
ECOG Performance Score 
0 1004 (51.5) 10541 (59.6) 
<0.001 
1 622 (31.9) 5217 (29.5) 
>2 325 (16.7) 1938 (11.0) 
Missing 52 307 
Current smoker 
No 1741 (86.9) 15933 (88.5) 
0.04 
Yes 262 (13.1) 2070 (11.5) 
Pre-existing respiratory condition 
No 1801 (89.9) 15948 (88.6) 
0.081 
Yes 202 (10.1) 2055 (11.4) 
Revised Cardiac Risk Index 
0 537 (26.8) 5544 (30.8) 
<0.001 1 1048 (52.3) 9202 (51.1) 
2 336 (16.8) 2582 (14.3) 
>3 82 (4.1) 675 (3.7)  
Disease factors 
Disease stage 
Early disease 889 (53.3) 9886 (55.1) 
0.164 Advanced/nodal disease 778 (46.7) 8045 (44.9) 
Missing 336 72 
Site specific cancer 
Head and neck 344 (17.2) 3173 (17.6) 
<0.001 
Colon 170 (8.5) 3260 (18.1) 
Rectal 188 (9.4) 1325 (7.4) 
Gastric 75 (3.7) 648 (3.6) 
Oesophageal 125 (6.2) 326 (1.8) 
Thoracic 124 (6.2) 1068 (5.9) 
Liver 77 (3.8) 698 (3.9) 
Pancreatic 145 (7.2) 631 (3.5) 
Sarcoma 49 (2.4) 389 (2.2) 
Prostate 93 (4.6) 444 (2.5) 
Kidney or upper tract urothelial 69 (3.4) 373 (2.1) 
Bladder 40 (2.0) 107 (0.6) 
Gynaecological 183 (9.1) 1986 (11.0) 
Breast 321 (16.0) 3575 (19.9) 
Treatment factors 
Neoadjuvant therapy 
No neoadjuvant 1353 (67.5) 15622 (86.8) 
<0.001 Neoadjuvant therapy, standard care 164 (8.2) 1736 (9.6) 
Neoadjuvant therapy, COVID decision 486 (24.3) 645 (3.6) 
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Percentages expressed of column total. SD=Standard deviation. ASA=American Society of Anaesthesiologists classification. ECOG=Eastern Cooperative Oncology Group. 
COVID=Coronavirus disease 2019. SARS-CoV-2=severe acute respiratory syndrome coronavirus 2. *Community SARS-CoV-2 rates were defined as the median 14-day cumulative 
case notification rate per 100,000 population between the date of local emergence of the pandemic up to the date of surgery for operated patients or cessation of follow-up (31st August 
2020) for non-operated patients. 
 
Supplementary table 4. Multivariable cox proportionate regression model of factors associated with surgical 
capacity during COVID-19 (presented in Figure 2) 
 
Factor Levels N= HR (univariable) HR (multivariable) 
COVID-19 Stringency Index group 
Light restrictions 4520  - - 
Moderate lockdown 3622  0.78 (0.74-0.81, p<0.001) 0.81 (0.77-0.84, p<0.001) 
Full lockdown 11678  0.47 (0.46-0.49, p<0.001) 0.51 (0.50-0.53, p<0.001) 
World Bank Income Classification 
High income 15733  - - 
Upper middle income 1864  0.93 (0.88-0.98, p=0.004) 0.97 (0.92-1.02, p=0.220) 
Lower middle income 2232  0.74 (0.70-0.78, p<0.001) 0.83 (0.78-0.87, p<0.001) 
Age 
<50 years 3669  - - 
50-59 years 4102  1.07 (1.02-1.13, p=0.003) 1.10 (1.05-1.15, p<0.001) 
60-69 years 5362  1.05 (1.00-1.10, p=0.037) 1.09 (1.04-1.14, p=0.001) 
70-79 years 4804  1.12 (1.07-1.17, p<0.001) 1.17 (1.11-1.23, p<0.001) 
>80 years 1895  1.06 (1.00-1.12, p=0.066) 1.06 (0.99-1.14, p=0.077) 
Sex 
Female 11398  - - 
Male 8434  0.89 (0.86-0.92, p<0.001) 0.99 (0.95-1.02, p=0.457) 
ASA Grade 
Grade 1-2 14033  - - 
Grade 3-5 5722  0.98 (0.95-1.02, p=0.307) 0.99 (0.95-1.03, p=0.533) 
ECOG Performance Score 
0 11445  - - 
1 5789  0.93 (0.90-0.96, p<0.001) 0.96 (0.92-0.99, p=0.020) 
>2 2247  0.90 (0.86-0.95, p<0.001) 0.89 (0.84-0.94, p<0.001) 
Current smoker 
No 17521  - - 
Yes 2311  1.04 (0.99-1.09, p=0.108) 1.03 (0.99-1.08, p=0.171) 
Pre-existing respiratory condition 
No 17591  - - 
Yes 2241  1.02 (0.97-1.07, p=0.391) 0.98 (0.94-1.03, p=0.472) 
Revised Cardiac Risk Index 
0 6059  - - 
1 10137  0.90 (0.87-0.93, p<0.001) 1.01 (0.95-1.07, p=0.779) 
2 2882  0.87 (0.83-0.91, p<0.001) 0.96 (0.89-1.03, p=0.245) 
>3 754  0.85 (0.78-0.92, p<0.001) 0.90 (0.81-1.00, p=0.044) 
Disease stage 
Early disease 10695  - - 
Advanced/nodal disease 8748  0.96 (0.93-0.99, p=0.008) 0.96 (0.93-0.99, p=0.018) 
Cancer location 
Head and neck 3505  - - 
Colon 3419  1.21 (1.15-1.27, p<0.001) 1.16 (1.08-1.24, p<0.001) 
Rectal 1491  0.63 (0.59-0.67, p<0.001) 0.59 (0.54-0.64, p<0.001) 
Gastric 717  0.69 (0.63-0.75, p<0.001) 0.67 (0.61-0.74, p<0.001) 
Oesophageal 444  0.33 (0.30-0.37, p<0.001) 0.32 (0.28-0.36, p<0.001) 
Thoracic 1184  0.93 (0.87-1.00, p=0.036) 0.82 (0.76-0.90, p<0.001) 
Liver 762  0.69 (0.63-0.75, p<0.001) 0.63 (0.57-0.69, p<0.001) 
Pancreatic 749  0.75 (0.69-0.82, p<0.001) 0.73 (0.66-0.81, p<0.001) 
Sarcoma 426  0.71 (0.64-0.79, p<0.001) 0.67 (0.60-0.75, p<0.001) 
Prostate 522  0.51 (0.47-0.57, p<0.001) 0.44 (0.40-0.50, p<0.001) 
Kidney or upper tract urothelial 433  0.72 (0.65-0.80, p<0.001) 0.65 (0.57-0.73, p<0.001) 
Bladder 142  0.59 (0.49-0.72, p<0.001) 0.51 (0.42-0.62, p<0.001) 
Gynaecological 2159  0.95 (0.90-1.00, p=0.062) 0.86 (0.79-0.93, p<0.001) 
Breast 3879  0.88 (0.84-0.92, p<0.001) 1.00 (0.94-1.05, p=0.884) 
 
Surgical capacity defined as patients booked for surgery undergoing an operation during the follow-up window. Percentages expressed of row total. SD=Standard deviation. 
ASA=American Society of Anaesthesiologists classification. ECOG=Eastern Cooperative Oncology Group. COVID=Coronavirus disease 2019. SARS-CoV-2=severe acute respiratory 
syndrome coronavirus 2. *Community SARS-CoV-2 rates were defined as the median 14-day cumulative case notification rate per 100,000 population between the date of local 
emergence of the pandemic up to the date of surgery for operated patients or cessation of follow-up (31st August 2020) for non-operated patients, and were stratified by World Bank 
income group to account for differences in access to SARS-CoV-2 testing and reporting across settings. Number in dataframe = 19832, Number in model = 19066, Missing = 766, 




Supplementary table 5. Sensitivity analysis of primary model for factors associated with surgical capacity during 
COVID-19 (outcome definition including elective surgery only) 
 
Factor Levels N= HR (univariable) HR (multivariable) 
COVID-19 Stringency Index group 
Light restrictions 4520  - - 
Moderate lockdown 3622  0.78 (0.75-0.82, p<0.001) 0.82 (0.78-0.86, p<0.001) 
Full lockdown 11678  0.48 (0.46-0.49, p<0.001) 0.53 (0.51-0.55, p<0.001) 
World Bank Income Classification 
High income 15733  - - 
Upper middle income 1864  0.84 (0.80-0.89, p<0.001) 0.87 (0.82-0.92, p<0.001) 
Lower middle income 2232  0.72 (0.69-0.76, p<0.001) 0.80 (0.75-0.84, p<0.001) 
Age 
<50 years 3669  - - 
50-59 years 4102  1.09 (1.03-1.14, p=0.001) 1.11 (1.06-1.17, p<0.001) 
60-69 years 5362  1.05 (1.01-1.10, p=0.027) 1.10 (1.05-1.16, p<0.001) 
70-79 years 4804  1.13 (1.08-1.18, p<0.001) 1.19 (1.13-1.26, p<0.001) 
>80 years 1895  1.05 (0.99-1.11, p=0.124) 1.08 (1.01-1.15, p=0.033) 
Sex 
Female 11398  - - 
Male 8434  0.87 (0.84-0.90, p<0.001) 0.98 (0.95-1.02, p=0.388) 
ASA Grade 
Grade 1-2 14033  - - 
Grade 3-5 5722  0.97 (0.94-1.00, p=0.059) 0.98 (0.94-1.02, p=0.281) 
ECOG Performance Score 
0 11445  - - 
1 5789  0.91 (0.88-0.94, p<0.001) 0.95 (0.92-0.99, p=0.006) 
>2 2247  0.86 (0.82-0.91, p<0.001) 0.87 (0.82-0.92, p<0.001) 
Current smoker 
No 17521  - - 
Yes 2311  1.03 (0.98-1.08, p=0.273) 1.02 (0.98-1.08, p=0.331) 
Pre-existing respiratory condition 
No 17591  - - 
Yes 2241  1.02 (0.98-1.07, p=0.323) 0.99 (0.94-1.04, p=0.607) 
Revised Cardiac Risk Index 
0 6059  - - 
1 10137  0.87 (0.84-0.90, p<0.001) 1.00 (0.94-1.07, p=0.886) 
2 2882  0.82 (0.78-0.86, p<0.001) 0.94 (0.87-1.02, p=0.138) 
>3 754  0.80 (0.73-0.87, p<0.001) 0.89 (0.79-0.99, p=0.026) 
Disease stage 
Early disease 10695  - - 
Advanced/nodal disease 8748  0.93 (0.90-0.96, p<0.001) 0.94 (0.91-0.97, p<0.001) 
Cancer location 
Head and neck 3505  - - 
Colon 3419  1.14 (1.08-1.19, p<0.001) 1.08 (1.00-1.16, p=0.040) 
Rectal 1491  0.60 (0.57-0.65, p<0.001) 0.57 (0.52-0.62, p<0.001) 
Gastric 717  0.66 (0.61-0.73, p<0.001) 0.65 (0.59-0.72, p<0.001) 
Oesophageal 444  0.33 (0.30-0.37, p<0.001) 0.31 (0.28-0.36, p<0.001) 
Thoracic 1184  0.95 (0.89-1.02, p=0.153) 0.83 (0.76-0.90, p<0.001) 
Liver 762  0.68 (0.63-0.74, p<0.001) 0.62 (0.56-0.68, p<0.001) 
Pancreatic 749  0.74 (0.68-0.81, p<0.001) 0.71 (0.64-0.79, p<0.001) 
Sarcoma 426  0.72 (0.64-0.80, p<0.001) 0.67 (0.59-0.75, p<0.001) 
Prostate 522  0.53 (0.48-0.58, p<0.001) 0.44 (0.39-0.50, p<0.001) 
Kidney or upper tract urothelial 433  0.67 (0.59-0.74, p<0.001) 0.59 (0.52-0.67, p<0.001) 
Bladder 142  0.58 (0.48-0.71, p<0.001) 0.50 (0.41-0.62, p<0.001) 
Gynaecological 2159  0.95 (0.90-1.01, p=0.083) 0.85 (0.79-0.93, p<0.001) 
Breast 3879  0.90 (0.85-0.94, p<0.001) 1.01 (0.96-1.07, p=0.729) 
 
Surgical capacity defined as patients booked for surgery undergoing an operation during the follow-up window. Percentages expressed of row total. SD=Standard deviation. 
ASA=American Society of Anaesthesiologists classification. ECOG=Eastern Cooperative Oncology Group. COVID=Coronavirus disease 2019. SARS-CoV-2=severe acute respiratory 
syndrome coronavirus 2. *Community SARS-CoV-2 rates were defined as the median 14-day cumulative case notification rate per 100,000 population between the date of local emergence 
of the pandemic up to the date of surgery for operated patients or cessation of follow-up (31st August 2020) for non-operated patients, and were stratified by World Bank income group to 
account for differences in access to SARS-CoV-2 testing and reporting across settings.  Number in dataframe = 19832, Number in model = 19066, Missing = 766, Number of events = 




Supplementary table 6. Sensitivity analysis of primary model for factors associated with surgical capacity during 
COVID-19 (cancer location removed) 
 
Factor Levels N= HR (univariable) HR (multivariable) 
COVID-19 Stringency Index group 
Light restrictions 4520  - - 
Moderate lockdown 3622  0.78 (0.74-0.81, p<0.001) 0.80 (0.76-0.83, p<0.001) 
Full lockdown 11678  0.47 (0.46-0.49, p<0.001) 0.51 (0.49-0.53, p<0.001) 
World Bank Income Classification 
High income 15733  - - 
Upper middle income 1864  0.93 (0.88-0.98, p=0.004) 1.01 (0.96-1.06, p=0.733) 
Lower middle income 2232  0.74 (0.70-0.78, p<0.001) 0.86 (0.81-0.90, p<0.001) 
Age 
<50 years 3669  - - 
50-59 years 4102  1.07 (1.02-1.13, p=0.003) 1.08 (1.03-1.14, p=0.001) 
60-69 years 5362  1.05 (1.00-1.10, p=0.037) 1.07 (1.02-1.12, p=0.005) 
70-79 years 4804  1.12 (1.07-1.17, p<0.001) 1.19 (1.13-1.25, p<0.001) 
>80 years 1895  1.06 (1.00-1.12, p=0.066) 1.17 (1.09-1.25, p<0.001) 
Sex 
Female 11398  - - 
Male 8434  0.89 (0.86-0.92, p<0.001) 0.88 (0.85-0.90, p<0.001) 
ASA Grade 
Grade 1-2 14033  - - 
Grade 3-5 5722  0.98 (0.95-1.02, p=0.307) 1.01 (0.97-1.05, p=0.547) 
ECOG Performance Score 
0 11445  - - 
1 5789  0.93 (0.90-0.96, p<0.001) 0.97 (0.93-1.00, p=0.088) 
>2 2247  0.90 (0.86-0.95, p<0.001) 0.95 (0.89-1.00, p=0.047) 
Current smoker 
No 17521  - - 
Yes 2311  1.04 (0.99-1.09, p=0.108) 1.06 (1.01-1.11, p=0.023) 
Pre-existing respiratory condition 
No 17591  - - 
Yes 2241  1.02 (0.97-1.07, p=0.391) 1.00 (0.95-1.05, p=0.880) 
Revised Cardiac Risk Index 
0 6059  - - 
1 10137  0.90 (0.87-0.93, p<0.001) 0.80 (0.77-0.83, p<0.001) 
2 2882  0.87 (0.83-0.91, p<0.001) 0.76 (0.72-0.80, p<0.001) 
>3 754  0.85 (0.78-0.92, p<0.001) 0.75 (0.69-0.82, p<0.001) 
Disease stage 
Early disease 10695  - - 
Advanced/nodal disease 8748  0.96 (0.93-0.99, p=0.008) 0.98 (0.95-1.01, p=0.190) 
 
Surgical capacity defined as patients booked for surgery undergoing an operation during the follow-up window. Percentages expressed of row total. SD=Standard deviation. 
ASA=American Society of Anaesthesiologists classification. ECOG=Eastern Cooperative Oncology Group. COVID=Coronavirus disease 2019. SARS-CoV-2=severe acute respiratory 
syndrome coronavirus 2. *Community SARS-CoV-2 rates were defined as the median 14-day cumulative case notification rate per 100,000 population between the date of local emergence 
of the pandemic up to the date of surgery for operated patients or cessation of follow-up (31st August 2020) for non-operated patients, and were stratified by World Bank income group to 
account for differences in access to SARS-CoV-2 testing and reporting across settings. Number in dataframe = 19832, Number in model = 19066, Missing = 766, Number of events = 




Supplementary table 7a. Sensitivity analysis of factors associated with surgical capacity during COVID-19 (World 
Bank Income groups, with interaction term by COVID-19 stringency index group) 
 
Factor Levels N= HR (univariable) HR (multivariable) 
Full lockdown *  
Upper middle income 
Interaction - 0.85 (0.74-0.99, p=0.033) 0.85 (0.73-0.99, p=0.031) 
Full lockdown *  
Lower middle income 
Interaction - 0.88 (0.75-1.02, p=0.096) 0.83 (0.71-0.97, p=0.019) 
Moderate lockdown * 
Upper middle income 
Interaction - 0.57 (0.47-0.68, p<0.001) 0.64 (0.54-0.77, p<0.001) 
Moderate lockdown *  
Lower middle income 
Interaction - 1.09 (0.88-1.34, p=0.430) 1.29 (1.04-1.59, p=0.019) 
COVID-19 Stringency Index group 
Light restrictions 4520  - - 
Moderate lockdown 3622  0.81 (0.77-0.85, p<0.001) 0.82 (0.78-0.86, p<0.001) 
Full lockdown 11678  0.48 (0.47-0.50, p<0.001) 0.52 (0.50-0.55, p<0.001) 
World Bank Income Classification 
High income 15733  - - 
Upper middle income 1864  1.27 (1.11-1.45, p=0.001) 1.17 (1.02-1.34, p=0.021) 
Lower middle income 2232  0.95 (0.83-1.10, p=0.511) 0.94 (0.81-1.08, p=0.396) 
Age 
<50 years 3669  - - 
50-59 years 4102  1.07 (1.02-1.13, p=0.003) 1.10 (1.05-1.15, p<0.001) 
60-69 years 5362  1.05 (1.00-1.10, p=0.037) 1.09 (1.04-1.14, p<0.001) 
70-79 years 4804  1.12 (1.07-1.17, p<0.001) 1.17 (1.11-1.23, p<0.001) 
>80 years 1895  1.06 (1.00-1.12, p=0.066) 1.07 (1.00-1.14, p=0.067) 
Sex 
Female 11398  - - 
Male 8434  0.89 (0.86-0.92, p<0.001) 0.99 (0.95-1.03, p=0.562) 
ASA Grade 
Grade 1-2 14033  - - 
Grade 3-5 5722  0.98 (0.95-1.02, p=0.307) 0.98 (0.95-1.02, p=0.419) 
ECOG Performance Score 
0 11445  - - 
1 5789  0.93 (0.90-0.96, p<0.001) 0.96 (0.92-0.99, p=0.017) 
>2 2247  0.90 (0.86-0.95, p<0.001) 0.89 (0.84-0.94, p<0.001) 
Current smoker 
No 17521  - - 
Yes 2311  1.04 (0.99-1.09, p=0.108) 1.04 (0.99-1.09, p=0.144) 
Pre-existing respiratory condition 
No 17591  - - 
Yes 2241  1.02 (0.97-1.07, p=0.391) 0.98 (0.94-1.03, p=0.478) 
Revised Cardiac Risk Index 
0 6059  - - 
1 10137  0.90 (0.87-0.93, p<0.001) 1.00 (0.94-1.07, p=0.897) 
2 2882  0.87 (0.83-0.91, p<0.001) 0.95 (0.88-1.03, p=0.221) 
>3 754  0.85 (0.78-0.92, p<0.001) 0.90 (0.81-0.99, p=0.038) 
Disease stage 
Early disease 10695  - - 
Advanced/nodal disease 8748  0.96 (0.93-0.99, p=0.008) 0.96 (0.93-1.00, p=0.025) 
Cancer location 
Head and neck 3505  - - 
Colon 3419  1.21 (1.15-1.27, p<0.001) 1.15 (1.07-1.23, p<0.001) 
Rectal 1491  0.63 (0.59-0.67, p<0.001) 0.58 (0.54-0.63, p<0.001) 
Gastric 717  0.69 (0.63-0.75, p<0.001) 0.67 (0.61-0.74, p<0.001) 
Oesophageal 444  0.33 (0.30-0.37, p<0.001) 0.32 (0.28-0.36, p<0.001) 
Thoracic 1184  0.93 (0.87-1.00, p=0.036) 0.82 (0.75-0.90, p<0.001) 
Liver 762  0.69 (0.63-0.75, p<0.001) 0.62 (0.57-0.69, p<0.001) 
Pancreatic 749  0.75 (0.69-0.82, p<0.001) 0.73 (0.66-0.81, p<0.001) 
Sarcoma 426  0.71 (0.64-0.79, p<0.001) 0.67 (0.59-0.75, p<0.001) 
Prostate 522  0.51 (0.47-0.57, p<0.001) 0.44 (0.40-0.50, p<0.001) 
Kidney or upper tract urothelial 433  0.72 (0.65-0.80, p<0.001) 0.65 (0.57-0.73, p<0.001) 
Bladder 142  0.59 (0.49-0.72, p<0.001) 0.52 (0.43-0.64, p<0.001) 
Gynaecological 2159  0.95 (0.90-1.00, p=0.062) 0.85 (0.79-0.92, p<0.001) 
Breast 3879  0.88 (0.84-0.92, p<0.001) 0.98 (0.93-1.04, p=0.501) 
Surgical capacity defined as patients booked for surgery undergoing an operation during the follow-up window. Percentages expressed of row total. SD=Standard deviation. 
ASA=American Society of Anaesthesiologists classification. ECOG=Eastern Cooperative Oncology Group. COVID=Coronavirus disease 2019. SARS-CoV-2=severe acute respiratory 
syndrome coronavirus 2. *Community SARS-CoV-2 rates were defined as the median 14-day cumulative case notification rate per 100,000 population between the date of local emergence 
of the pandemic up to the date of surgery for operated patients or cessation of follow-up (31st August 2020) for non-operated patients, and were stratified by World Bank income group to 
account for differences in access to SARS-CoV-2 testing and reporting across settings. Number in dataframe = 19832, Number in model = 19066, Missing = 766, Number of events = 




Supplementary table 7b. Sensitivity analysis of factors associated with surgical capacity during COVID-19 (World 
Bank Income groups, with stratified hazard ratios by stringency index group) 
 
Factor Levels N= HR (univariable) HR (multivariable) 
COVID-19 Stringency Index group by 
income group 
Light restrictions  
* High income 
4088  - - 
Light restrictions  
* Upper middle income 
228  1.27 (1.11-1.45, p=0.001) 1.17 (1.02-1.34, p=0.021) 
Light restrictions  
* Lower middle income 
204  0.95 (0.83-1.10, p=0.511) 0.94 (0.81-1.08, p=0.396) 
Moderate lockdown  
* High income 
3116  0.81 (0.77-0.85, p<0.001) 0.82 (0.78-0.86, p<0.001) 
Moderate lockdown  
* Upper middle income 
316  0.58 (0.51-0.66, p<0.001) 0.62 (0.55-0.70, p<0.001) 
Moderate lockdown  
* Lower middle income 
190  0.84 (0.72-0.98, p=0.024) 1.00 (0.85-1.16, p=0.960) 
Full lockdown  
* High income 
8529  0.48 (0.47-0.50, p<0.001) 0.52 (0.50-0.55, p<0.001) 
Full lockdown  
* Upper middle income 
1311  0.52 (0.49-0.56, p<0.001) 0.52 (0.49-0.56, p<0.001) 
Full lockdown  
* Lower middle income 
1838  0.41 (0.38-0.43, p<0.001) 0.41 (0.38-0.44, p<0.001) 
Age 
<50 years 3669  - - 
50-59 years 4102  1.07 (1.02-1.13, p=0.003) 1.10 (1.05-1.15, p<0.001) 
60-69 years 5362  1.05 (1.00-1.10, p=0.037) 1.09 (1.04-1.14, p<0.001) 
70-79 years 4804  1.12 (1.07-1.17, p<0.001) 1.17 (1.11-1.23, p<0.001) 
>80 years 1895  1.06 (1.00-1.12, p=0.066) 1.07 (1.00-1.14, p=0.067) 
Sex 
Female 11398  - - 
Male 8434  0.89 (0.86-0.92, p<0.001) 0.99 (0.95-1.03, p=0.562) 
ASA Grade 
Grade 1-2 14033  - - 
Grade 3-5 5722  0.98 (0.95-1.02, p=0.307) 0.98 (0.95-1.02, p=0.419) 
ECOG Performance Score 
0 11445  - - 
1 5789  0.93 (0.90-0.96, p<0.001) 0.96 (0.92-0.99, p=0.017) 
>2 2247  0.90 (0.86-0.95, p<0.001) 0.89 (0.84-0.94, p<0.001) 
Current smoker 
No 17521  - - 
Yes 2311  1.04 (0.99-1.09, p=0.108) 1.04 (0.99-1.09, p=0.144) 
Pre-existing respiratory condition 
No 17591  - - 
Yes 2241  1.02 (0.97-1.07, p=0.391) 0.98 (0.94-1.03, p=0.478) 
Revised Cardiac Risk Index 
0 6059  - - 
1 10137  0.90 (0.87-0.93, p<0.001) 1.00 (0.94-1.07, p=0.897) 
2 2882  0.87 (0.83-0.91, p<0.001) 0.95 (0.88-1.03, p=0.221) 
>3 754  0.85 (0.78-0.92, p<0.001) 0.90 (0.81-0.99, p=0.038) 
Disease stage 
Early disease 10695  - - 
Advanced/nodal disease 8748  0.96 (0.93-0.99, p=0.008) 0.96 (0.93-1.00, p=0.025) 
Cancer location 
Head and neck 3505  - - 
Colon 3419  1.21 (1.15-1.27, p<0.001) 1.15 (1.07-1.23, p<0.001) 
Rectal 1491  0.63 (0.59-0.67, p<0.001) 0.58 (0.54-0.63, p<0.001) 
Gastric 717  0.69 (0.63-0.75, p<0.001) 0.67 (0.61-0.74, p<0.001) 
Oesophageal 444  0.33 (0.30-0.37, p<0.001) 0.32 (0.28-0.36, p<0.001) 
Thoracic 1184  0.93 (0.87-1.00, p=0.036) 0.82 (0.75-0.90, p<0.001) 
Liver 762  0.69 (0.63-0.75, p<0.001) 0.62 (0.57-0.69, p<0.001) 
Pancreatic 749  0.75 (0.69-0.82, p<0.001) 0.73 (0.66-0.81, p<0.001) 
Sarcoma 426  0.71 (0.64-0.79, p<0.001) 0.67 (0.59-0.75, p<0.001) 
Prostate 522  0.51 (0.47-0.57, p<0.001) 0.44 (0.40-0.50, p<0.001) 
Kidney or upper tract urothelial 433  0.72 (0.65-0.80, p<0.001) 0.65 (0.57-0.73, p<0.001) 
Bladder 142  0.59 (0.49-0.72, p<0.001) 0.52 (0.43-0.64, p<0.001) 
Gynaecological 2159  0.95 (0.90-1.00, p=0.062) 0.85 (0.79-0.92, p<0.001) 
Breast 3879  0.88 (0.84-0.92, p<0.001) 0.98 (0.93-1.04, p=0.501) 
Surgical capacity defined as patients booked for surgery undergoing an operation during the follow-up window. Percentages expressed of row total. SD=Standard deviation. 
ASA=American Society of Anaesthesiologists classification. ECOG=Eastern Cooperative Oncology Group. COVID=Coronavirus disease 2019. SARS-CoV-2=severe acute respiratory 
syndrome coronavirus 2. *Community SARS-CoV-2 rates were defined as the median 14-day cumulative case notification rate per 100,000 population between the date of local emergence 
of the pandemic up to the date of surgery for operated patients or cessation of follow-up (31st August 2020) for non-operated patients, and were stratified by World Bank income group to 
account for differences in access to SARS-CoV-2 testing and reporting across settings. Number in dataframe = 19832, Number in model = 19066, Missing = 766, Number of events = 








Supplementary table 9. Differences in proportions of patients in each age group across settings 
 
 Age group 
 <50 years* 50-59 years 60-69 years 70-79 years >80 years 
Status at cessation of follow-up 
 













Operated Not operated Operated 
High income, low COVID 10 (2.5) 685 (20.8) 9 (2.3) 925 (24.7) 13 (2.3) 1228 (25.3) 6 (1.4) 1135 (25.7) 7 (3.2) 445 (26.3) 
High income, high COVID 153 (37.8) 1296 (39.4) 203 (51.0) 1904 (50.9) 390 (70.3) 2832 (58.2) 358 (84.4) 2905 (65.7) 193 (87.7) 1166 (69.0) 
Upper middle income, low COVID 9 (2.2) 208 (6.3) 12 (3.0) 160 (4.3) 20 (3.6) 186 (3.8) 13 (3.1) 97 (2.2) 4 (1.8) 29 (1.7) 
Upper middle income, high COVID 33 (8.1) 287 (8.7) 35 (8.8) 241 (6.4) 35 (6.3) 293 (6.0) 18 (4.2) 167 (3.8) 8 (3.6) 36 (2.1) 
Lower middle income, low COVID 24 (5.9) 679 (20.7) 29 (7.3) 441 (11.8) 19 (3.4) 276 (5.7) 8 (1.9) 100 (2.3) 2 (0.9) 12 (0.7) 
Lower middle income, high COVID 176 (43.5) 132 (4.0) 110 (27.6) 68 (1.8) 78 (14.1) 48 (1.0) 21 (5.0) 18 (0.4) 6 (2.7) 2 (0.1) 
COVID=Coronavirus disease 2019. SARS-CoV-2=severe acute respiratory syndrome coronavirus 2. *Included patients <50 years of age, and 50-59 years of age were more likely to be from lower middle income countries. This may explain 
the reduced odds of patients <50 years undergoing surgery during the follow-up window (residual confounding after multivariable adjustment).   
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Supplementary table 10. Reasons that patients remained non-operated <50 versus >50 years of age 
 
Reasons 
<50 years  
(N=405) 











Multidisciplinary team decision to delay surgery due to patient risk during COVID-19 335 82.7% 1121 70.2% 1456 
Change to alternative treatment modality because of COVID-19 48 11.9% 485 30.4% 533 
Patient choice to avoid surgery during COVID-19 pandemic 72 17.8% 388 24.3% 460 
Ongoing neoadjuvant therapy (COVID-decision) 94 23.2% 284 17.8% 378 
No bed/critical care bed/operating room space available due to COVID-19 87 21.5% 212 13.3% 299 
Change of recommendations in society guidelines related to COVID-19 42 10.4% 178 11.1% 220 
Patient unable to travel to hospital related to COVID- 19 67 16.5% 73 4.6% 140 
Collateral impact on supporting services causing delay 3 0.7% 21 1.3% 24 
Patient delayed due to SARS-CoV-2 infection 2 0.5% 21 1.3% 23 
Died of COVID-19 whilst waiting for surgery 0 0.0% 13 0.8% 13 
Not COVID-19 related 
Disease progression leading to change in treatment plan 10 2.5% 154 9.6% 164 
Delay due to other medical or surgical condition 3 0.7% 56 3.5% 59 
Died unrelated to COVID-19 whilst waiting for surgery 6 1.5% 29 1.8% 35 
Patient unable to afford surgery 5 1.2% 19 1.2% 24 
Patient choice to avoid surgery unrelated to COVID-19 5 1.2% 14 0.9% 19 
Disease regression leading to change in definitive treatment plan 1 0.2% 7 0.4% 8 
 
COVID=Coronavirus disease 2019. SARS-CoV-2=severe acute respiratory syndrome coronavirus 2. Reasons which were more common in the <50 years age group are highlighted 
in bold. Two patients (0.1%) had no reasons given for non-operation during the follow-up window selected (missing data). Proportions are therefore expressed as a percentage of 
2001 non-operated patients with that reason given and with data available. We anticipated that decisions to delay or cancel surgery during COVID-19 would be complex. Therefore, 
selecting more than one reason for non-operation during the follow-up window for each patient was permitted. One patient could have both one or more COVID-19 related and not 




Supplementary table 11. Sensitivity analysis of primary model for factors associated with surgical capacity 
during COVID-19 (patients >50 years old only, N=16163) 
 
Factor Levels N= HR (univariable) HR (multivariable) 
COVID-19 Stringency Index group 
Light restrictions 3745  - - 
Moderate lockdown 3061  0.78 (0.75-0.82, p<0.001) 0.81 (0.77-0.85, p<0.001) 
Full lockdown 9345  0.48 (0.46-0.50, p<0.001) 0.52 (0.49-0.54, p<0.001) 
World Bank Income Classification 
High income 13603  - - 
Upper middle income 1331  0.93 (0.88-0.99, p=0.017) 0.95 (0.90-1.01, p=0.113) 
Lower middle income 1226  0.78 (0.73-0.84, p<0.001) 0.87 (0.81-0.93, p<0.001) 
Age 
50-59 years 4102  - - 
60-69 years 5362  0.98 (0.94-1.02, p=0.272) 0.99 (0.95-1.04, p=0.795) 
70-79 years 4804  1.04 (1.00-1.09, p=0.048) 1.07 (1.02-1.12, p=0.005) 
>80 years 1895  0.98 (0.93-1.04, p=0.580) 0.97 (0.91-1.04, p=0.374) 
Sex 
Female 8828  - - 
Male 7335  0.88 (0.85-0.91, p<0.001) 0.98 (0.94-1.02, p=0.404) 
ASA Grade 
Grade 1-2 10750  - - 
Grade 3-5 5345  0.97 (0.93-1.00, p=0.056) 0.99 (0.95-1.03, p=0.529) 
ECOG Performance Score 
0 8578  - - 
1 5160  0.93 (0.89-0.96, p<0.001) 0.95 (0.92-0.99, p=0.014) 
>2 2122  0.90 (0.86-0.95, p<0.001) 0.89 (0.84-0.94, p<0.001) 
Current smoker 
No 14315  - - 
Yes 1848  1.04 (0.99-1.10, p=0.114) 1.02 (0.97-1.08, p=0.385) 
Pre-existing respiratory condition 
No 14108  - - 
Yes 2055  0.99 (0.94-1.04, p=0.686) 0.98 (0.93-1.03, p=0.393) 
Revised Cardiac Risk Index 
0 4079  - - 
1 8581  0.84 (0.81-0.87, p<0.001) 1.01 (0.94-1.08, p=0.767) 
2 2756  0.81 (0.77-0.85, p<0.001) 0.96 (0.89-1.04, p=0.339) 
>3 747  0.79 (0.72-0.85, p<0.001) 0.90 (0.81-1.01, p=0.069) 
Disease stage 
Early disease 8758  - - 
Advanced/nodal disease 7109  0.96 (0.93-1.00, p=0.030) 0.95 (0.92-0.99, p=0.007) 
Cancer location 
Head and neck 2598  - - 
Colon 3125  1.10 (1.04-1.16, p=0.001) 1.10 (1.02-1.18, p=0.015) 
Rectal 1307  0.59 (0.55-0.63, p<0.001) 0.57 (0.53-0.63, p<0.001) 
Gastric 610  0.64 (0.58-0.70, p<0.001) 0.65 (0.58-0.72, p<0.001) 
Oesophageal 408  0.30 (0.26-0.34, p<0.001) 0.30 (0.26-0.34, p<0.001) 
Thoracic 1099  0.85 (0.79-0.92, p<0.001) 0.80 (0.73-0.87, p<0.001) 
Liver 682  0.64 (0.59-0.70, p<0.001) 0.61 (0.55-0.67, p<0.001) 
Pancreatic 643  0.70 (0.63-0.76, p<0.001) 0.70 (0.63-0.78, p<0.001) 
Sarcoma 261  0.64 (0.56-0.73, p<0.001) 0.60 (0.52-0.69, p<0.001) 
Prostate 513  0.47 (0.42-0.52, p<0.001) 0.43 (0.38-0.48, p<0.001) 
Kidney or upper tract urothelial 370  0.66 (0.58-0.74, p<0.001) 0.62 (0.54-0.70, p<0.001) 
Bladder 127  0.51 (0.42-0.63, p<0.001) 0.46 (0.37-0.57, p<0.001) 
Gynaecological 1669  0.87 (0.82-0.93, p<0.001) 0.81 (0.75-0.89, p<0.001) 
Breast 2751  0.83 (0.78-0.87, p<0.001) 0.96 (0.90-1.02, p=0.164) 
 
Surgical capacity defined as patients booked for surgery undergoing an operation during the follow-up window. Percentages expressed of row total. SD=Standard deviation. 
ASA=American Society of Anaesthesiologists classification. ECOG=Eastern Cooperative Oncology Group. COVID=Coronavirus disease 2019. SARS-CoV-2=severe acute respiratory 
syndrome coronavirus 2. *Community SARS-CoV-2 rates were defined as the median 14-day cumulative case notification rate per 100,000 population between the date of local emergence 
of the pandemic up to the date of surgery for operated patients or cessation of follow-up (31st August 2020) for non-operated patients, and were stratified by World Bank income group to 
account for differences in access to SARS-CoV-2 testing and reporting across settings. Number in dataframe = 16163, Number in model = 15539, Missing = 624, Number of events = 







Supplementary table 12. Non-operation rate during lockdowns across SARS-CoV-2 rate groups 
 
 Full lockdown Moderate lockdown Light restrictions 
SARS-CoV-2 case notification rate group Operated Not operated Operated Not operated Operated Not operated 
High income, low COVID 345 (94.0) 22 (6.0) 1138 (99.5) 6 (0.5) 2935 (99.4) 17 (0.6) 
High income, high COVID 7111 (85.9) 1166 (14.1) 1860 (93.7) 126 (6.3) 1132 (99.6) 5 (0.4) 
Upper middle income, low COVID 245 (93.5) 17 (6.5) 208 (83.9) 40 (16.1) 227 (99.6) 1 (0.4) 
Upper middle income, high COVID 945 (88.6) 122 (11.4) 70 (90.9) 7 (9.1) 0 (0.0) 0 (0.0) 
Lower middle income, low COVID 1138 (94.4) 67 (5.6) 169 (93.4) 12 (6.6) 201 (98.5) 3 (1.5) 
Lower middle income, high COVID 268 (41.3) 381 (58.7) 0 (0.0) 10 (100.0) 0 (0.0) 0 (0.0) 




Supplementary table 13. Secondary analysis of factors associated with surgical capacity during COVID-19 
(SARS-CoV-2 case notification rate groups) 
 
Factor Levels N= HR (univariable) HR (multivariable) 
COVID-19 Stringency Index group 
Light restrictions 4520  - - 
Moderate lockdown 3622  0.78 (0.74-0.81, p<0.001) 0.84 (0.80-0.88, p<0.001) 
Full lockdown 11678  0.47 (0.46-0.49, p<0.001) 0.57 (0.54-0.60, p<0.001) 
Community SARS-CoV-2 case 
notification rate* 
High income, low COVID 4459  - - 
High income, high COVID 11274  0.60 (0.58-0.62, p<0.001) 0.89 (0.85-0.93, p<0.001) 
Upper middle income, low COVID 727  0.77 (0.71-0.83, p<0.001) 0.91 (0.84-0.99, p=0.030) 
Upper middle income, high COVID 1137  0.57 (0.53-0.61, p<0.001) 0.85 (0.78-0.92, p<0.001) 
Lower middle income, low COVID 1587  0.76 (0.72-0.80, p<0.001) 1.06 (0.99-1.14, p=0.076) 
Lower middle income, high COVID 645  0.17 (0.15-0.20, p<0.001) 0.27 (0.24-0.31, p<0.001) 
Age 
<50 years 3669  - - 
50-59 years 4102  1.07 (1.02-1.13, p=0.003) 1.11 (1.05-1.16, p<0.001) 
60-69 years 5362  1.05 (1.00-1.10, p=0.037) 1.09 (1.04-1.15, p<0.001) 
70-79 years 4804  1.12 (1.07-1.17, p<0.001) 1.18 (1.12-1.24, p<0.001) 
>80 years 1895  1.06 (1.00-1.12, p=0.066) 1.06 (1.00-1.14, p=0.067) 
Sex 
Female 11398  - - 
Male 8434  0.89 (0.86-0.92, p<0.001) 1.00 (0.97-1.04, p=0.938) 
ASA Grade 
Grade 1-2 14033  - - 
Grade 3-5 5722  0.98 (0.95-1.02, p=0.307) 0.98 (0.94-1.02, p=0.267) 
ECOG Performance Score 
0 11445  - - 
1 5789  0.93 (0.90-0.96, p<0.001) 0.94 (0.91-0.98, p=0.002) 
>2 2247  0.90 (0.86-0.95, p<0.001) 0.90 (0.85-0.95, p<0.001) 
Current smoker 
No 17521  - - 
Yes 2311  1.04 (0.99-1.09, p=0.108) 1.05 (1.00-1.10, p=0.039) 
Pre-existing respiratory condition 
No 17591  - - 
Yes 2241  1.02 (0.97-1.07, p=0.391) 0.98 (0.93-1.03, p=0.417) 
Revised Cardiac Risk Index 
0 6059  - - 
1 10137  0.90 (0.87-0.93, p<0.001) 1.00 (0.94-1.06, p=0.938) 
2 2882  0.87 (0.83-0.91, p<0.001) 0.94 (0.87-1.02, p=0.120) 
>3 754  0.85 (0.78-0.92, p<0.001) 0.88 (0.80-0.98, p=0.021) 
Disease stage 
Early disease 10695  - - 
Advanced/nodal disease 8748  0.96 (0.93-0.99, p=0.008) 0.96 (0.93-0.99, p=0.012) 
Cancer location 
Head and neck 3505  - - 
Colon 3419  1.21 (1.15-1.27, p<0.001) 1.13 (1.05-1.21, p=0.001) 
Rectal 1491  0.63 (0.59-0.67, p<0.001) 0.57 (0.52-0.62, p<0.001) 
Gastric 717  0.69 (0.63-0.75, p<0.001) 0.65 (0.59-0.72, p<0.001) 
Oesophageal 444  0.33 (0.30-0.37, p<0.001) 0.30 (0.27-0.35, p<0.001) 
Thoracic 1184  0.93 (0.87-1.00, p=0.036) 0.80 (0.73-0.87, p<0.001) 
Liver 762  0.69 (0.63-0.75, p<0.001) 0.60 (0.55-0.66, p<0.001) 
Pancreatic 749  0.75 (0.69-0.82, p<0.001) 0.70 (0.64-0.78, p<0.001) 
Sarcoma 426  0.71 (0.64-0.79, p<0.001) 0.63 (0.56-0.71, p<0.001) 
Prostate 522  0.51 (0.47-0.57, p<0.001) 0.42 (0.37-0.47, p<0.001) 
Kidney or upper tract urothelial 433  0.72 (0.65-0.80, p<0.001) 0.61 (0.54-0.69, p<0.001) 
Bladder 142  0.59 (0.49-0.72, p<0.001) 0.50 (0.41-0.62, p<0.001) 
Gynaecological 2159  0.95 (0.90-1.00, p=0.062) 0.85 (0.78-0.91, p<0.001) 
Breast 3879  0.88 (0.84-0.92, p<0.001) 0.91 (0.86-0.96, p<0.001) 
Surgical capacity defined as patients booked for surgery undergoing an operation during the follow-up window. Percentages expressed of row total. SD=Standard deviation. ASA=American 
Society of Anaesthesiologists classification. ECOG=Eastern Cooperative Oncology Group. COVID=Coronavirus disease 2019. SARS-CoV-2=severe acute respiratory syndrome coronavirus 
2. *Community SARS-CoV-2 rates were defined as the median 14-day cumulative case notification rate per 100,000 population between the date of local emergence of the pandemic up to 
the date of surgery for operated patients or cessation of follow-up (31st August 2020) for non-operated patients, and were stratified by World Bank income group to account for differences in 
access to SARS-CoV-2 testing and reporting across settings. Number in dataframe = 19832, Number in model = 19066, Missing = 766, Number of events = 17597, Concordance = 0.636 
(SE = 0.002), R-squared = 0.171( Max possible = 1.000), Likelihood ratio test = 3574.260 (df = 34, p = 0.000)  
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Supplementary table 14. Treatment intervals across SARS-CoV-2 case notification rate groups 
 





















Straight to surgery 
0-4 weeks 1263 (31.2) 2318 (26.6) 228 (37.9) 302 (32.5) 545 (49.5) 70 (33.0) 
<0.001 
5-8 weeks 1755 (43.4) 3111 (35.6) 175 (29.1) 207 (22.3) 295 (26.8) 53 (25.0) 
9-12 weeks 596 (14.7) 1632 (18.7) 99 (16.4) 131 (14.1) 121 (11.0) 22 (10.4) 
>12 weeks 432 (10.7) 1669 (19.1) 100 (16.6) 290 (31.2) 139 (12.6) 67 (31.6) 
Neoadjuvant therapy (standard care) 
0-4 weeks 29 (8.9) 64 (6.9) 7 (9.7) 1 (1.6) 7 (2.3) 2 (5.1) 
<0.001 
5-8 weeks 25 (7.7) 48 (5.1) 6 (8.3) 2 (3.2) 14 (4.6) 0 (0.0) 
9-12 weeks 37 (11.4) 73 (7.8) 11 (15.3) 4 (6.5) 15 (4.9) 1 (2.6) 
>12 weeks 234 (72.0) 749 (80.2) 48 (66.7) 55 (88.7) 268 (88.2) 36 (92.3) 
Neoadjuvant therapy (COVID decision) 
0-4 weeks 10 (21.3) 20 (4.6) 0 (0.0) 1 (3.1) 2 (1.9) 1 (5.9) 
<0.001 
5-8 weeks 10 (21.3) 78 (17.8) 0 (0.0) 2 (6.2) 6 (5.8) 3 (17.6) 
9-12 weeks 8 (17.0) 104 (23.7) 2 (33.3) 5 (15.6) 18 (17.3) 2 (11.8) 
>12 weeks 19 (40.4) 237 (54.0) 4 (66.7) 24 (75.0) 78 (75.0) 11 (64.7) 
 




Supplementary table 15. System friction during lockdowns 
 
Interval Summary Light restrictions Moderate lockdown Full lockdown P-value 
Straight to surgery 
Weeks diagnosis to operation Mean (SD) 5.7 (4.4) 5.9 (4.6) 7.8 (5.9) <0.001 
   Weeks diagnosis to decision Mean (SD) 2.8 (3.5) 2.7 (3.5) 3.1 (3.9) <0.001 
   Weeks decision to operation Mean (SD) 2.9 (2.4) 3.2 (2.8) 4.7 (4.5) <0.001 
Neoadjuvant therapy (standard care) 
Weeks diagnosis to operation Mean (SD) 15.3 (8.1) 15.8 (7.0) 17.4 (6.1) <0.001 
   Weeks diagnosis to decision Mean (SD) 11.6 (8.3) 9.7 (8.4) 9.7 (30.3) 0.488 
   Weeks decision to operation Mean (SD) 3.7 (3.0) 6.1 (5.4) 9.4 (30.1) 0.001 
Neoadjuvant therapy (COVID decision) 
Weeks diagnosis to operation Mean (SD) 8.4 (6.5) 9.9 (6.2) 14.7 (6.1) <0.001 
   Weeks diagnosis to decision Mean (SD) 4.8 (6.9) 3.6 (5.8) 4.9 (5.8) 0.214 




Supplementary table 16. Characteristics of operated patients that went straight to surgery (no neoadjuvant 
therapy) grouped by time from diagnosis to operation (N=15622) 
   
Interval diagnosis to surgery   
Factor Levels 0-4 weeks 5-8 weeks 9-12 weeks >12 weeks P-value 
Health system factors 
COVID-19 Stringency Index 
group 
Light restrictions 1372 (33.0) 1813 (43.7) 588 (14.2) 379 (9.1) 
<0.001 Moderate lockdown 1020 (33.4) 1244 (40.7) 476 (15.6) 317 (10.4) 
Full lockdown 2333 (27.8) 2533 (30.1) 1535 (18.3) 2001 (23.8) 
Weeks in full lockdown Mean (SD) 7.2 (4.9) 6.8 (4.8) 7.7 (4.5) 10.0 (5.0) <0.001 
World Bank Income 
Classification 
High income 3581 (28.0) 4866 (38.1) 2228 (17.4) 2101 (16.4) 
<0.001 Upper middle income 530 (34.6) 382 (24.9) 230 (15.0) 390 (25.5) 
Lower middle income 615 (46.9) 348 (26.5) 143 (10.9) 206 (15.7) 
SARS-CoV-2 case 
notification rate 
High income, low COVID 1263 (31.2) 1755 (43.4) 596 (14.7) 432 (10.7) 
<0.001 
High income, high COVID 2318 (26.6) 3111 (35.6) 1632 (18.7) 1669 (19.1) 
Upper middle income, low COVID 228 (37.9) 175 (29.1) 99 (16.4) 100 (16.6) 
Upper middle income, high COVID 302 (32.5) 207 (22.3) 131 (14.1) 290 (31.2) 
Lower middle income, low COVID 545 (49.5) 295 (26.8) 121 (11.0) 139 (12.6) 
Lower middle income, high COVID 70 (33.0) 53 (25.0) 22 (10.4) 67 (31.6) 
Patient factors 
Age 
<50 years 940 (35.1) 852 (31.8) 409 (15.3) 480 (17.9) 
<0.001 
50-59 years 1003 (31.5) 1174 (36.8) 493 (15.5) 519 (16.3) 
60-69 years 1234 (29.2) 1525 (36.0) 723 (17.1) 749 (17.7) 
70-79 years 1087 (27.7) 1501 (38.2) 698 (17.8) 644 (16.4) 
>80 years 463 (29.1) 545 (34.3) 278 (17.5) 305 (19.2) 
Sex 
Female 2726 (30.2) 3464 (38.4) 1441 (16.0) 1386 (15.4) 
<0.001 
Male 2001 (30.3) 2133 (32.3) 1160 (17.6) 1311 (19.8) 
ASA Grade 
ASA grade 1-2 3406 (30.9) 4005 (36.4) 1746 (15.9) 1853 (16.8) 
<0.001 ASA grade 3-5 1312 (28.6) 1576 (34.4) 851 (18.6) 841 (18.4) 
Missing 9 19 5 3 
ECOG Performance Score 
0 2778 (30.4) 3335 (36.5) 1439 (15.8) 1573 (17.2) 
0.002 
1 1332 (29.6) 1590 (35.4) 810 (18.0) 764 (17.0) 
>2 560 (32.1) 567 (32.5) 297 (17.0) 321 (18.4) 
Missing 60 110 68 69 
Current smoker 
No 4153 (30.1) 4931 (35.7) 2294 (16.6) 2424 (17.6) 
0.054 
Yes 574 (31.5) 666 (36.6) 307 (16.9) 273 (15.0) 
Pre-existing  
respiratory condition 
No 4249 (30.8) 4920 (35.7) 2262 (16.4) 2355 (17.1) 
<0.001 
Yes 478 (26.0) 677 (36.9) 339 (18.5) 342 (18.6) 
Revised Cardiac Risk Index 
0 1534 (32.4) 1810 (38.3) 751 (15.9) 637 (13.5) 
<0.001 
1 2372 (29.7) 2814 (35.3) 1310 (16.4) 1485 (18.6) 
2 654 (28.6) 775 (33.9) 429 (18.8) 430 (18.8) 
>3 167 (26.9) 198 (31.9) 111 (17.9) 145 (23.3) 
Disease factors 
Disease stage 
Early disease 2434 (27.0) 3271 (36.3) 1613 (17.9) 1685 (18.7) 
<0.001 Advanced/nodal disease 2271 (34.7) 2300 (35.1) 981 (15.0) 1002 (15.3) 
Missing 22 29 9 12 
Cancer site 
Head and neck 1011 (33.2) 1083 (35.6) 486 (16.0) 461 (15.2) 
<0.001 
Colon 1221 (38.6) 1004 (31.7) 503 (15.9) 439 (13.9) 
Rectal 232 (26.5) 306 (35.0) 130 (14.9) 206 (23.6) 
Gastric 149 (32.7) 126 (27.6) 76 (16.7) 105 (23.0) 
Oesophageal 26 (22.8) 32 (28.1) 13 (11.4) 43 (37.7) 
Thoracic 242 (23.3) 427 (41.1) 187 (18.0) 184 (17.7) 
Liver 98 (16.5) 182 (30.6) 153 (25.7) 162 (27.2) 
Pancreatic 203 (35.4) 187 (32.6) 86 (15.0) 98 (17.1) 
Sarcoma 78 (27.3) 79 (27.6) 57 (19.9) 72 (25.2) 
Prostate 20 (5.0) 86 (21.4) 82 (20.4) 213 (53.1) 
Kidney or upper tract urothelial 87 (23.4) 124 (33.3) 70 (18.8) 91 (24.5) 
Bladder 14 (14.4) 39 (40.2) 27 (27.8) 17 (17.5) 
Gynaecological 515 (28.4) 750 (41.4) 261 (14.4) 287 (15.8) 
Breast 831 (29.8) 1172 (42.0) 470 (16.8) 319 (11.4) 
Treatment factors 
Operation grade 
Major 3658 (29.7) 4303 (34.9) 2060 (16.7) 2297 (18.6) 
<0.001 Minor 1042 (32.4) 1268 (39.4) 530 (16.5) 381 (11.8) 
Missing 21 22 10 18 
Percentages expressed of row total. SD=Standard deviation. ASA=American Society of Anaesthesiologists classification. ECOG=Eastern Cooperative Oncology Group. 











Supplementary table 17. Outcomes by interval from diagnosis to operation for patients going straight to surgery (N=15622) 
 
  Interval diagnosis to surgery   
Outcome Levels 0-4 weeks 5-8 weeks 9-12 weeks >12 weeks Total P-value 
Margin status 
R0 4043 (85.6) 4791 (85.8) 2222 (85.2) 2280 (84.7) 13336 (85.1) 
0.019 
R1 328 (6.9) 441 (7.9) 202 (7.9) 217 (8.1) 1188 (7.7) 
R2 100 (2.1) 107 (1.9) 53 (2.0) 37 (1.4) 297 (1.9) 
Pathology unavailable 251 (5.3) 247 (4.4) 116 (4.5) 154 (5.7) 768 (4.9) 
Missing 5 11 8 9 33 
Resectable disease at time of surgery 
Resectable 4553 (96.3) 5508 (98.4) 2554 (98.2) 2645 (98.1) 15260 (97.7) 
<0.001 Unresectable 173 (3.7) 87 (1.6) 46 (1.8) 52 (1.9) 358 (2.3) 
Unknown 1 (0.0) 2 (0.0) 1 (0.0) 0 (0.0) 4 (0.0) 
Pre-operative cancer-related complication 
requiring emergency surgery 
Elective 4468 (94.7) 5547 (99.2) 2581 (99.4) 2674 (99.4) 15270 (97.9) 
<0.001 
Emergency 252 (5.3) 43 (0.8) 16 (0.6) 15 (0.6) 326 (2.1) 
30-day SARS-CoV-2 infection rate 
No 4685 (99.1) 5557 (99.3) 2577 (99.1) 2676 (99.2) 15495 (99.2) 
0.698 
Yes 42 (0.9) 40 (0.7) 24 (0.9) 21 (0.8) 127 (0.8) 
30-day postoperative mortality rate 
No 4652 (98.5) 5533 (98.9) 2570 (98.9) 2659 (98.9) 15414 (98.8) 
0.008 Yes 73 (1.5) 62 (1.1) 29 (1.1) 31 (1.1) 195 (1.2) 
Missing 2 2 2 7 13 
New detection of  
metastatic disease* 
No 2694 (98.1) 2967 (97.8) 1454 (98.7) 1656 (98.4) 8771 (98.1) 
0.085 Yes 51 (1.9) 66 (2.3) 18 (1.3) 24 (1.6) 159 (1.9) 
Missing 4 5 4 14 27 
COVID=Coronavirus disease 2019. SARS-CoV-2=severe acute respiratory syndrome coronavirus 2. Resection margin status classified as R0=No microscopic or macroscopic disease, R1=Microscopic disease at the 
margin, R2=Macroscopic disease at the margin. *Detailed data on detection of new metastatic disease not collected for liver, pancreatic, breast and gynaecological cancers. Patients with metastatic disease at baseline 








Supplementary table 18. Outcomes across SARS-CoV-2 case notification rate groups for patients going straight to surgery (no neoadjuvant therapy) 
(N=15622) 
 


























R0 3397 (84.1) 7462 (85.7) 509 (84.8) 797 (85.9) 975 (88.8) 194 (91.5) 13334 (85.5) 
<0.001 
R1 372 (9.2) 683 (7.8) 35 (5.8) 66 (7.1) 28 (2.6) 4 (1.9) 1188 (7.7) 
R2 90 (2.2) 144 (1.6) 14 (2.3) 30 (3.2) 17 (1.5) 2 (0.9) 297 (1.9) 
Pathology unavailable 182 (4.5) 420 (4.8) 43 (7.1) 35 (3.8) 76 (7.0) 12 (5.7) 768 (4.9) 
Missing 5 21 1 2 4 0 33 
Resectable disease at time of surgery 
Resectable 3970 (98.1) 8567 (98.1) 580 (96.3) 895 (96.2) 1040 (94.5) 206 (97.2) 15258 (97.7) 
<0.001 Unresectable 74 (1.8) 161 (1.8) 22 (3.7) 35 (3.8) 60 (5.5) 6 (2.8) 358 (2.3) 
Unknown 2 (0.0) 2 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 4 (0.0) 
Pre-operative cancer-related complication 
requiring emergency surgery 
Elective 3978 (98.4) 8562 (98.3) 581 (97.0) 893 (96.0) 1052 (95.7) 202 (95.3) 15268 (97.9) 
<0.001 
Emergency 63 (1.6) 151 (1.7) 18 (3.0) 37 (4.0) 47 (4.3) 10 (4.7) 326 (2.1) 
30-day SARS-CoV-2 infection rate 
No 3988 (98.6) 8697 (99.6) 601 (99.8) 916 (98.5) 1081 (98.3) 210 (99.1) 15493 (99.2) 
<0.001 
Yes 58 (1.4) 33 (0.4) 1 (0.2) 14 (1.5) 19 (1.7) 2 (0.9) 127 (0.8) 
30-day postoperative mortality rate 
No 3980 (98.4) 8641 (99.1) 594 (98.7) 917 (98.6) 1074 (97.6) 206 (97.2) 15412 (98.8) 
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COVID=Coronavirus disease 2019. SARS-CoV-2=severe acute respiratory syndrome coronavirus 2. Resection margin status classified as R0=No microscopic or macroscopic disease, R1=Microscopic disease at the margin, R2=Macroscopic disease at 
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World Bank income 
group 
Date of first lockdown 




ARE United Arab Emirates High income Full, 26th March 2020 73.2 
AUT Austria High income Full, 16th March 2020 81.5 
BEL Belgium High income Full, 18th March 2020 73.2 
BRB Barbados High income Full, 28th March 2020 73.2 
CAN Canada High income Moderate (regional), 17th March 2020 43.5 
CHE Switzerland High income Full, 17th March 2020 73.2 
CYP Cyprus High income Full, 24th March 2020 92.6 
CZE Czech Republic High income Full, 16th March 2020 79.6 
DEU Germany High income Full, 22nd March 2020 76.9 
DNK Denmark High income Moderate (national), 12th March 2020 38.0 
ESP Spain High income Full, 14th March 2020 67.1 
FRA France High income Full, 17th March 2020 88.0 
GBR United Kingdom High income Full, 23rd March 2020 78.2 
GRC Greece High income Full, 23rd March 2020 84.3 
HRV Croatia High income Moderate (national), 19th March 2020 50.0 
HUN Hungary High income Full, 28th March 2020 76.9 
IRL Ireland High income Full, 28th March 2020 85.2 
ITA Italy High income Full, 9th March 2020 74.5 
JPN Japan High income Moderate (national) only, 7th April 2020 43.5 
KWT Kuwait High income Full, 10th May 2020 100.0 
LTU Lithuania High income Full, 16th March 2020 81.5 
NLD Netherlands High income Moderate (national), 15th March 2020 53.7 
OMN Oman High income Full, 10th April 2020 92.6 
PAN Panama High income Full, 25th March 2020 75.9 
POL Poland High income Moderate (national), 13th March 2020 41.7 
PRT Portugal High income Full, 19th March 2020 82.4 
SAU Saudi Arabia High income Moderate (regional), 9th March 2020 30.6 
SGP Singapore High income Full, 8th April 2020 76.9 
USA United States High income Moderate (regional) only 17 March 2020 55.1 
ALB Albania Upper middle income Full, 13th March 2020 78.7 
ARG Argentina Upper middle income Full, 19th March 2020 100.0 
AZE Azerbaijan Upper middle income Full, 31st March 2020 88.89 
BGR Bulgaria Upper middle income Moderate (national), 13th March 2020 50.93 
BRA Brazil Upper middle income Moderate (regional) only, 17th March 2020 57.9 
BWA Botswana Upper middle income Full, 2nd April 2020 86.11 
COL Colombia Upper middle income Full, 25th March 2020 87.96 
JOR Jordan Upper middle income Full, 18th March 2020 100 
LBY Libya Upper middle income Full, 22nd March 2020 77.78 
LKA Sri Lanka Upper middle income Full, 18th March 2020 81.48 
MEX Mexico Upper middle income Moderate (national), 24th March 2020 52.78 
MYS Malaysia Upper middle income Full, 18th March 2020 73.15 
PER Peru Upper middle income Full, 16th March 2020 90.74 
ROU Romania Upper middle income Full, 25th March 2020 78.7 
RUS Russian Federation Upper middle income Full, 28th March 2020 71.7 
SRB Serbia Upper middle income Moderate (national), 15th March 2020 49.07 
TUR Turkey Upper middle income Full, 28th March 2020 75.9 
ZAF South Africa Upper middle income Full, 26th March 2020 88 
EGY Egypt Lower middle income Full, 25th March 2020 84.3 
ETH Ethiopia Lower middle income Full, 8th April 2020 80.6 
GHA Ghana Lower middle income Moderate (regional) only, 26th March 2020 52.8 
IND India Lower middle income Full, 25th March 2020 100.0 
MAR Morocco Lower middle income Moderate (national), 19th March 2020 55.56 
MDG Madagascar Lower middle income Full, 23rd March 2020 91.67 
NGA Nigeria Lower middle income Moderate (regional) only, 23rd March 2020 48.6 
PAK Pakistan Lower middle income Full, 24th March 2020 93.5 
PHL Philippines Lower middle income Full, 15th March 2020 75.0 
PSE Palestine Lower middle income Full, 7th March 2020 74.07 






Appendix C. Indicators in the Oxford COVID-19 government response index 
 
Indicator Name Type Targeted/general? Maximum value (levels) 
Containment and closure 
 C1 School closing Ordinal Geographic 3 (0, 1, 2, 3) 
 C2 Workplace closing Ordinal Geographic 3 (0, 1, 2, 3) 
 C3 Cancel public events Ordinal Geographic 2 (0, 1, 2) 
 C4 Restrictions on gathering size Ordinal Geographic 4 (0, 1, 2, 3, 4) 
 C5 Close public transport Ordinal Geographic 2 (0, 1, 2) 
 C6 Stay-at-home requirements Ordinal Geographic 3 (0, 1, 2, 3) 
 C7 Restrictions on internal movement Ordinal Geographic 2 (0, 1, 2) 
 C8 Restrictions on international travel Ordinal No 4 (0, 1, 2, 3, 4) 
Economic response 
 E1 Income support Ordinal Sectoral 2 (0, 1, 2) 
 E2 Debt/contract relief for households Ordinal No 2 (0, 1, 2) 
Health systems 
 H1 Public information campaign Ordinal Geographic 2 (0, 1, 2) 
 H2 Testing policy Ordinal No 3 (0, 1, 2, 3) 
 H3 Contact tracing Ordinal No 2 (0, 1, 2) 
 H6 Facial coverings Ordinal Geographic 4 (0, 1, 2, 3, 4) 
 H7 Vaccination policy Ordinal Funding 5 (0, 1, 2, 3, 4, 5) 
 
13 indicators are included in the Oxford COVID-19 government response index (overall) which are used for this analysis. Published in Hale, T., Angrist, N., Goldszmidt, 





Appendix D. Use of the Oxford COVID-19 Government Stringency index 
In order to define the national government response to COVID-19 for each patient in each included country, 
we used the stringency index from the Oxford COVID-19 government response tracker. The COVID-19 
stringency index is a data-driven tool for policy and research that measures how the response of 
governments has varied in response to COVID-19 at a national level with across 19 indicators including 
‘lockdown’ measures and behavioural interventions aimed at reducing population mobility (1). The index 
has been validated by demonstrating associations with population SARS-CoV-2 infection rates and Google 
mobile phone mobility data. The stringency index was highly associated with population mobility in 
validation data and was best targeted towards the impact of restrictive governmental interventions on 
surgical capacity, so was chosen for use in this study.  
 
In this study, three groupings of the level of ‘lockdown’ based on COVID-19 stringency index scores were 
adopted: (1) Light restrictions (index score <20); (2) Moderate lockdown (index score 20<x<60); (3) Full 
lockdown (index score >60). Recognising variability in definitions of lockdown across included countries, 
the selection of a cut-point for a ‘full lockdown’ was validated by using national policy, media and press 
sources to identify the date of first national ‘lockdown’ for a sample of participating high-income, upper 
middle-income and lower middle-income countries, and extracting the point estimate for the COVID-19 
stringency index score on the date of lockdown (Appendix C). If no ‘full lockdown’ was reported to have 
occurred, a representative date where some restrictive measures were imposed at either a national or 
regional level (i.e., a ‘moderate lockdown’) was selected. Whilst all participating hospitals were in areas 
affected by COVID-19, the definition of ‘light restrictions’ aimed to emulate ‘normal circumstances’ as 
closely as possible to allow internal comparison within the dataset between periods of ‘full lockdown’ and 
essentially normal care.  
 
For each patient, a median average score whilst waiting for surgery and the number of weeks in full 
lockdown were calculated and used in analyses. We considered several methods of measuring the overall 
exposure of each included patient including median average from diagnosis to surgery or censorship, point 
estimates at the time of diagnosis or decision for surgery (study entry) and ‘area under the stringency 
curve’ (sum of stringency scores multiplied by duration of exposure). Whilst the point estimate at the time of 
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study entry (date of decision for surgery) would minimise any impact of future information bias, whereby 
patients may be more likely to be exposed to several lockdown states therefore demonstrate a central 
tendency (i.e., classified as moderate lockdown overall) we felt that this would misrepresent the complex 
and dynamic nature of lockdowns, and risk underestimating or overestimating patients’ overall exposure. 
Supporting this decision, we did not see a central tendency in the distribution of calculated median. 
Balancing the risks and benefits of each method of processing the Oxford COVID-19 government response 
index we took a pragmatic decision to adopt the median average score for all included analyses. 
 
Appendix E. Challenges with use of SARS-CoV-2 case notification rates  
 
Accurate estimation of a country’s SARS-CoV-2 burden is challenging. For example, studies from Zambia 
and India using post-mortem records and population level sampling have demonstrated a significant 
underestimation (100-times and higher) of SARS-CoV-2 infection rates and subsequent COVID-related 
deaths (2, 3). Cross-reactivity with other pathogens endemic in Sub-Saharan Africa has also been reported. 
Therefore, case rates were used for exploratory analyses only, and stratified by World Bank income tertile. 
Data on SARS-CoV-2 rates were extracted from the World Health Organisation, European Centre for 
Disease Control, US Centre for Disease Control and specific national registries via the Our World in Data 
portal (4). Case notification rates for SARS-CoV-2 reflect the ability of health systems to identify exposed 





Appendix F. Patient level variable descriptions and definitions 
Patient level variables included age, sex, American Society of Anaesthesiologists grade, Eastern 
Cooperative Oncology Group (ECOG) performance status, smoking status, pre-existing respiratory 
condition, and Revised Cardiac Risk Index (RCRI). To account for different tumour grading and staging 
systems across the included cancer types, disease status was classified at the time of decision for surgery 
as early stage (organ confined, non-nodal, non-metastatic, fully resectable) or advanced stage (growth 
beyond organ, nodal, metastatic operated with curative intent). For analyses of surgical outcomes, grade of 
surgery was categorised based on the Clinical Coding & Schedule Development Group as either Minor 





Appendix G. Estimation of treatment intervals 
In order to estimate the impact of lockdown of treatment delays, the relationship between lockdowns and 
the interval from diagnosis to surgery was explored. The date of diagnosis was defined pragmatically as the 
date when diagnostic imaging, laboratory samples, multidisciplinary team discussion, or an outpatient clinic 
diagnosis was made (whichever was earliest). The interval from date of diagnosis to the date of surgery 
was calculated in whole weeks. Accepting that there are likely to be significant differences in the ‘normal’ 
interval from diagnosis to surgery across different health systems, a ‘delay’ from diagnosis to surgery was 
not specifically defined. Several different interval groups were defined pragmatically in 4-week epochs 
according to describe differences between intervals from diagnosis to surgery and surgical quality. The 
association between lockdowns and interval from diagnosis to surgery was primarily explored in patients 
with neoadjuvant therapy (i.e. that went ‘straight to surgery’). 
 
In secondary exploration, the point of ‘system friction’ was also reported to compare differences in intervals 
from diagnosis to decision for surgery, and from decision to operation. Date of decision for surgery was 
again defined pragmatically as the date of multidisciplinary team discussion, or surgeon’s decision to book 




Appendix H. Classification of reasons for non-operation 
Reflecting the complexity of surgical decision making during the pandemic, more than one reason could be 
selected for non-operation for any single patient. One patient therefore could have both COVID-19 related 
and not COVID-related reason(s) selected. Where it was unclear whether a reason was directly or indirectly 
COVID-related (for example, disease progression leading to change in treatment plan) this was attributed 
as a non-COVID-19 related reason. In practice, it is complex to summarise the exact processes 
underpinning reasons for treatment delay in this complex multi-specialty and multi-country dataset. These 
reasons are provided to illustrate the common themes in the data and explore: (1) to what extent 
cancellation and delay could have been expected as part of ‘normal’ (pre-pandemic) practice; (2) estimate 





Appendix I. Definitions of secondary outcomes for operated patients 
The full protocol definitions of each included secondary outcome were: 
• Resection margin status: R0: No microscopic or macroscopic disease, R1: Microscopic disease at 
the margin, R2: Macroscopic disease at the margin, Pathology unavailable: No histopathological 
analysis performed or reported, Missing: Missing data). 
• Resectable disease at the time of surgery (resectable/unresectable). Unresectable disease was 
defined by the operating surgeon as surgery performed with a palliative intent (i.e., for symptomatic 
management, non-curative only) or an abandoned procedure due to concerns around resectability. 
• Pre-operative cancer-related complication requiring emergency surgery e.g., obstructed bowel, 
bleeding at the tumour site. Emergency surgery was defined as an unplanned admission requiring 
surgery within hours of decision to operate. 
• 30-day postoperative SARS-CoV-2 infection rate, confirmed by RT-qPCR testing of a 
nasopharyngeal swab, or an indicative CT thorax or clinical diagnosis of symptomatic COVID-19 in 
patients for whom swab testing was unavailable (6, 7). 
• 30-day postoperative mortality rate (8-10). 
• New detection of metastatic disease up to a maximum of 30-days after surgery. Metastatic disease 
was defined upon postoperative histological staging, or upon restaging radiological examination 
where this was performed. Data on detection of new metastatic disease was not collected for liver, 
pancreatic, breast and gynaecological cancers, therefore rates of detection of new metastatic 







Appendix J. Full statistical methodology 
 
No pre-specified sample size calculation was performed. Missing data were included in flowcharts and 
summary tables, but excluded from the models. We pre-planned to conduct multiple imputation by chained 
equations if the level of missingness for variables included in the model was greater than 5%. Non-
parametric data were summarised with medians and interquartile ranges and differences between groups 
were tested using the Mann-Whitney U test. Parametric data were summarised with mean average and 
standard deviation. Differences between groups were explored using two-tailed Student’s t-test (two 
comparator groups) or one-way Analysis of Variance (ANOVA, three or more comparator groups) The χ2 
test was used for categorical data. Cox proportional hazards regression modelling was used to explore 
association between lockdowns and the primary outcome, presented as adjusted hazard ratios (HR) and 
95% confidence intervals. Operation was included as the outcome event, and no censoring was performed 
for death or progression to unresectable disease to deal with competing risks, given individuals had the 
same follow-up time (i.e., describing sub-distribution rather than cause-specific hazards). The proportional 
hazards (PH) assumption was checked using the Schoenfeld individual test and graphical diagnostics 
based on the scaled Schoenfeld residuals. The proportional hazard assumption was accepted if a non-
significant relationship was detected between residuals and time. Clinically plausible health-system, patient, 
and disease-related factors were selected a priori for inclusion in adjusted analyses. Testing for non-linear 
relationship with the outcome variable was performed for continuous variables by including a penalised 
spline on the exposure, and plotting a spline term. Where significant non-linear relationships were 
demonstrated, variables were categorised before inclusion in the model. An alpha level was set at 0.05 






Appendix K. Further discussion of study topics 
 
Protecting elective surgery pathways 
The demand on critical care services during COVID-19 has been unprecedented. Protecting a small 
proportion of dedicated critical care beds, even when community SARS-CoV-2 incidence is high, will 
support vulnerable patients and those with advanced disease to undergo the cancer surgery they require. 
Newer ways of working, including dedicated postoperative units that can provide adequate support for 
several surgical patients with lower staffing demands, may be necessary (7). These may need to be away 
from acute sites that may be subject to COVID-19 surges. 
 
Relationship between COVID-19, lockdowns and non-operation 
Whilst all patients had a stated reasons for non-operation related to COVID-19, only a proportion of this 
were seemingly directly attributable to lockdown measures (for example, patients being unable to travel to 
hospital during periods with travel restrictions). We hypothesise that country-level stringency measures 
have a direct impact on hospital procedures and planning through lockdown-related hospital/institutional 
policies i.e., that health systems change to reflect stringent government policies on containment and 
movement restriction. This is corroborated by a sensitivity analysis which demonstrated that full and 
moderate lockdowns independently increased the likelihood of non-operation after adjustment for local 
SARS-CoV-2 case notification rates. This has important policy implications. Whilst the collateral impact of 
COVID-19 on other health conditions has been widely discussed, there is little published primary data (i.e., 
not modelled) that provides information about the direct effects of lockdowns on non-communicable 
disease (11). These data provide important insight for governments when balancing decisions about 
whether to extend, increase or decrease the stringency of lockdowns, and the broader societal 
consequences.  
 
Perspectives for policy during future waves  
Resilience of elective cancer surgery remains low across all settings (12). Stepping back up to a full 
capacity service requires advanced planning to cope with future predicted demand. The added complexities 
of potential future lockdowns mean that expenditure on protected elective capacity for cancer surgery 
should be considered now by policy makers at national levels. Future lockdowns under current conditions 
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will worsen outcomes for patients needing cancer surgery against a background of mounting backlogs and 
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